Macquarie Group LTD Zai Lab LTD Transaction History

Macquarie Group LTD

$87.4 Billion
Q1 2024

A detailed history of Macquarie Group LTD transactions in Zai Lab LTD stock. As of the latest transaction made, Macquarie Group LTD holds 425 shares of ZLAB stock, worth $7,365. This represents 0.0% of its overall portfolio holdings.

Number of Shares

425

Previous 5,901 92.8%

Holding current value

$7,365

Previous $161,000 96.27%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$15.95 - $26.8 $87,342 - $146,756	-5,476 Reduced 92.8%	425 $6,000
Q3 2023 Nov 14, 2023	SELL	$22.72 - $31.49 $60,026 - $83,196	-2,642 Reduced 30.93%	5,901 $143,000
Q2 2023 Aug 14, 2023	BUY	$25.3 - $39.67 $60,239 - $94,454	2,381 Added 38.64%	8,543 $236,000
Q3 2022 Nov 14, 2022	BUY	$34.2 - $51.69 $37,551 - $56,755	1,098 Added 21.68%	6,162 $211,000
Q2 2022 Aug 15, 2022	SELL	$23.14 - $49.68 $1,018 - $2,185	-44 Reduced 0.86%	5,064 $175,000

Q1 2022 May 16, 2022	SELL	$27.77 - $64.4 $548,013 - $1.27 Million	-19,734 Reduced 79.44%	5,108 $225,000
Q4 2021 Feb 11, 2022	BUY	$54.9 - $105.21 $70,930 - $135,931	1,292 Added 5.49%	24,842 $1.56 Million
Q3 2021 Nov 12, 2021	BUY	$105.0 - $178.37 $1.54 Million - $2.62 Million	14,671 Added 165.23%	23,550 $2.48 Million
Q2 2021 Aug 13, 2021	BUY	$125.11 - $180.0 $234,331 - $337,140	1,873 Added 26.73%	8,879 $1.57 Million
Q1 2021 May 14, 2021	BUY	$126.27 - $191.71 $116,294 - $176,564	921 Added 15.14%	7,006 $934,000
Q4 2020 Feb 16, 2021	BUY	$81.94 - $135.34 $124,384 - $205,446	1,518 Added 33.24%	6,085 $823,000
Q3 2020 Nov 13, 2020	BUY	$73.3 - $89.48 $1,612 - $1,968	22 Added 0.48%	4,567 $380,000
Q2 2020 Aug 11, 2020	BUY	$48.82 - $82.53 $99,153 - $167,618	2,031 Added 80.79%	4,545 $374,000
Q1 2020 May 15, 2020	BUY	$39.1 - $62.9 $98,297 - $158,130	2,514 New	2,514 $129,000

Others Institutions Holding ZLAB

# of Institutions

124

Shares Held

39.9M

Call Options Held

41.2K

Put Options Held

190K

View Full List

About Zai Lab Ltd

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $1.7B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

More about ZLAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Zai Lab LTD Transaction History